Nov 27, 2020 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the advancements in pancreatic cancer treatment. This topic is especially timely. Not only is it Pancreatic Cancer Awareness Month but also Alex Trebek, the longtime host of Jeopardy, recently died from this...
Nov 20, 2020 | Featured, Podcast
On this week’s episode of the podcast, Terry and Bob discuss the advances in cancer treatment as a result of personalized and precision medicine. Unfortunately, these advances have been obviated by the Covid-19 pandemic, which has led countless patients to avoid...
Nov 2, 2020 | Featured, Federal Issues, Podcast
On this episode of the podcast, Terry and Bob discuss gene therapies, which have the potential to cure and treat many genetic disorders by delivering nucleic acids into patients’ cells and replacing genes. Gene therapies can be lifesaving for many patients, but...
Oct 17, 2020 | COVID-19, Featured, Podcast
On this week’s episode of the podcast, Bob reprises his interview with Janet Woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the FDA, about the hurdles to reshoring drug manufacturing to the U.S. Currently, roughly 80 percent of...
Oct 3, 2020 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the perverse status quo in the American healthcare system where those with rare and chronic diseases subsidize the healthy through the prescription drug rebate system. Each year, drugmakers pay hundreds of billions...
Sep 16, 2020 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss what goes into a drug price. They pull the curtain to reveal the group of middlemen between drugmakers and the patient that drives up the drug prices patients pay. They highlight the bizarre system of drug rebates,...
